Literature DB >> 1465622

Hepatic clearance of plasma low density lipoproteins.

D K Spady1.   

Abstract

An elevated plasma LDL concentration is a major risk factor for the development of atherosclerosis and coronary heart disease. The concentration of LDL in plasma is determined, to a large extent, by events in the liver, since this organ is the source of LDL (via VLDL) and is the major site of LDL catabolism. LDL uptake by the liver is mediated largely by receptor-dependent mechanisms and fully 80 to 90% of whole body receptor-dependent LDL catabolism occurs in the liver. The rate of receptor-dependent LDL uptake by the liver is influenced by dietary and genetic factors. Cholesterol and fatty acids are the major dietary factors that alter receptor-dependent LDL uptake by the liver and appear to do so by regulating LDL receptor gene transcription. Regulation of LDL receptor gene transcription by sterols is mediated by sterol regulatory elements within the LDL receptor promoter, but how the nucleus actually senses cellular cholesterol levels and how dietary fatty acids might influence this process remain to be elucidated. Genetic factors may affect the basal rate of receptor-dependent LDL transport or the sensitivity of the LDL receptor pathway to regulation by dietary lipids. An understanding of how dietary lipids regulate hepatic LDL transport and plasma LDL levels, and identification of the major genetic factors that determine responsiveness to dietary lipids is crucial to the development of safe and effective dietary guidelines and to the selection of individuals most likely to benefit from diet modification.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1465622     DOI: 10.1055/s-2008-1040407

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  20 in total

1.  Lutein prevents high fat diet-induced atherosclerosis in ApoE-deficient mice by inhibiting NADPH oxidase and increasing PPAR expression.

Authors:  Hao Han; Wei Cui; Linzhi Wang; Yufang Xiong; Liegang Liu; Xiufa Sun; Liping Hao
Journal:  Lipids       Date:  2015-02-07       Impact factor: 1.880

Review 2.  Human low-density lipoprotein receptor gene and its regulation.

Authors:  Wei-Jia Kong; Jingwen Liu; Jian-Dong Jiang
Journal:  J Mol Med (Berl)       Date:  2005-11-16       Impact factor: 4.599

3.  Regulation of hepatic 7 alpha-hydroxylase expression by dietary psyllium in the hamster.

Authors:  J D Horton; J A Cuthbert; D K Spady
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

4.  A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression.

Authors:  Amar Bahadur Singh; Chin Fung Kelvin Kan; Vikram Shende; Bin Dong; Jingwen Liu
Journal:  J Lipid Res       Date:  2014-05-02       Impact factor: 5.922

5.  The critical role of mRNA destabilizing protein heterogeneous nuclear ribonucleoprotein d in 3' untranslated region-mediated decay of low-density lipoprotein receptor mRNA in liver tissue.

Authors:  Amar Bahadur Singh; Hai Li; Chin Fung Kelvin Kan; Bin Dong; Mark R Nicolls; Jingwen Liu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-24       Impact factor: 8.311

6.  Reduction of circulating PCSK9 and LDL-C levels by liver-specific knockdown of HNF1α in normolipidemic mice.

Authors:  Vikram Ravindra Shende; Minhao Wu; Amar Bahadur Singh; Bin Dong; Chin Fung Kelvin Kan; Jingwen Liu
Journal:  J Lipid Res       Date:  2015-02-04       Impact factor: 5.922

7.  Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice.

Authors:  Amar Bahadur Singh; Bin Dong; Fredric B Kraemer; Yanyong Xu; Yanqiao Zhang; Jingwen Liu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

8.  Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production.

Authors:  Meihui Pan; Arthur I Cederbaum; Yuan-Li Zhang; Henry N Ginsberg; Kevin Jon Williams; Edward A Fisher
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  CETP inhibitors downregulate hepatic LDL receptor and PCSK9 expression in vitro and in vivo through a SREBP2 dependent mechanism.

Authors:  Bin Dong; Amar Bahadur Singh; Chin Fung; Kelvin Kan; Jingwen Liu
Journal:  Atherosclerosis       Date:  2014-06-04       Impact factor: 5.162

10.  A novel peroxisome proliferator response element modulates hepatic low-density lipoprotein receptor gene transcription in response to PPARδ activation.

Authors:  Vikram R Shende; Amar Bahadur Singh; Jingwen Liu
Journal:  Biochem J       Date:  2015-10-06       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.